Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 33211842

Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 May 13
First author
Hamadani M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 May 13;137(19):2568-2570. doi: 10.1182/blood.2020009782.
    note
    Source null
    related pmid
    33983420
    relationship
    Comment in

Authors and identifiers

  1. name
    Hamadani M
    type
    Author
  2. name
    Radford J
    type
    Author
  3. name
    Carlo-Stella C
    type
    Author
  4. name
    Caimi PF
    type
    Author
  5. name
    Reid E
    type
    Author
  6. name
    O'Connor OA
    type
    Author
  7. name
    Feingold JM
    type
    Author
  8. name
    Ardeshna KM
    type
    Author
  9. name
    Townsend W
    type
    Author
  10. name
    Solh M
    type
    Author
  11. name
    Heffner LT
    type
    Author
  12. name
    Ungar D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hamadani M
    type
    Author
  2. name
    Radford J
    type
    Author
  3. name
    Carlo-Stella C
    type
    Author
  4. name
    Caimi PF
    type
    Author
  5. name
    Reid E
    type
    Author
  6. name
    O'Connor OA
    type
    Author
  7. name
    Feingold JM
    type
    Author
  8. name
    Ardeshna KM
    type
    Author
  9. name
    Townsend W
    type
    Author
  10. name
    Solh M
    type
    Author
  11. name
    Heffner LT
    type
    Author
  12. name
    Ungar D
    type
    Author
bibliography ids
  1. nci-bib-d088719688ff3b88e273b634
book metadata
content sha256
511b423630bfd7096ed47efbdfde071374a0afd89f8107e634b0f8e62db9d5f8
document type
citation
dois
  1. 10.1182/blood.2020007512
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33211842
immutable id
pubmed:33211842@511b423630bfd7096ed47efbdfde071374a0afd89f8107e634b0f8e62db9d5f8
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
19
name
Blood
nlm unique id
7603509
pages
2634-2645
volume
137
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 May 13;137(19):2568-2570. doi: 10.1182/blood.2020009782.
    note
    Source null
    related pmid
    33983420
    relationship
    Comment in
outcomes validated
false
pmid
33211842
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
4e2971f2d3d92c5e8ee47524327cb8bcb2961023a9eb7261d645dea42f9b8541
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2021 May 13
precision
day
year
2021
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33211842/
title
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice